Sauve A A, Munshi C, Lee H C, Schramm V L
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Biochemistry. 1998 Sep 22;37(38):13239-49. doi: 10.1021/bi981248s.
Human recombinant CD38 catalyzes the formation of both cyclic ADP-ribose and ADP-ribose products from NAD+ and hydrolyzes cyclic ADP-ribose to ADP-ribose. The corresponding GDP products are formed from NGD+. The enzyme was characterized by substrate and inhibition kinetics, exchange studies, rapid-quench reactions, and stopped-flow-fluorescence spectroscopy to establish the reaction mechanism and energetics for individual steps. Noncyclizable substrates NMN+ and nicotinamide-7-deaza-hypoxanthine dinucleotide (7-deaza NHD+) were rapidly hydrolyzed by the enzyme. The kcat for NMN+ was 5-fold higher than that of NAD+ and has the greatest reported kcat of any substrate for CD38. 7-deaza-NHD+ was hydrolyzed at approximately one-third the rate of NHD+ but does not form a cyclic product. These results establish that a cyclic intermediate is not required for substrate hydrolysis. The ratio of methanolysis to hydrolysis for cADPR and NAD+ catalyzed by CD38 increases linearly with MeOH concentration. Both reactions produce predominantly the beta-methoxy riboside compound, with a relative nucleophilicity of MeOH to H2O of 11. These results indicate the existence of a stabilized cationic intermediate for all observed chemistries in the active site of CD38. The partitioning of this intermediate between cyclization, hydrolysis, and nicotinamide-exchange unites the mechanisms of CD38 chemistries. Steady-state and pre-steady-state parameters for the partition and exchange mechanisms allowed full characterization of the reaction coordinate. Stopped-flow methods indicate a burst of cGDPR formation followed by the steady-state reaction rate. A lag phase, which was NGD+ concentration dependent, was also observed. The burst size indicates that the dimeric enzyme has a single catalytic site formed by two subunits. Pre-steady-state quench experiments did not detect covalent intermediates. Nicotinamide hydrolysis of NGD+ precedes cyclization and the chemical quench decomposes the enzyme-bound species to a mixture of cyclic and hydrolysis products. The time dependence of this ratio indicated that nicotinamide bond-breakage occurs 4 times faster than the conversion of the intermediate to products. Product release is the overall rate-limiting step for enzyme reaction with NGD+.
人重组CD38催化由NAD⁺形成环状ADP - 核糖和ADP - 核糖产物,并将环状ADP - 核糖水解为ADP - 核糖。相应的GDP产物由NGD⁺形成。通过底物和抑制动力学、交换研究、快速淬灭反应以及停流荧光光谱对该酶进行表征,以确定各个步骤的反应机制和能量学。不可环化的底物NMN⁺和烟酰胺 - 7 - 脱氮次黄嘌呤二核苷酸(7 - 脱氮NHD⁺)被该酶快速水解。NMN⁺的kcat比NAD⁺高5倍,是报道的CD38所有底物中kcat最大的。7 - 脱氮 - NHD⁺的水解速率约为NHD⁺的三分之一,但不形成环状产物。这些结果表明底物水解不需要环状中间体。CD38催化的cADPR和NAD⁺的甲醇解与水解的比例随甲醇浓度线性增加。两个反应主要产生β - 甲氧基核糖苷化合物,甲醇对水的相对亲核性为11。这些结果表明在CD38活性位点的所有观察到的化学反应中存在稳定的阳离子中间体。该中间体在环化、水解和烟酰胺交换之间的分配统一了CD38化学反应的机制。分配和交换机制的稳态和预稳态参数允许对反应坐标进行全面表征。停流方法表明cGDPR形成有一个爆发期,随后是稳态反应速率。还观察到一个滞后阶段,其依赖于NGD⁺浓度。爆发大小表明二聚体酶有一个由两个亚基形成的单一催化位点。预稳态淬灭实验未检测到共价中间体。NGD⁺的烟酰胺水解先于环化,化学淬灭将酶结合的物种分解为环状和水解产物的混合物。该比例的时间依赖性表明烟酰胺键断裂发生的速度比中间体转化为产物的速度快4倍。产物释放是酶与NGD⁺反应的总体限速步骤。